Hyperlipoproteinemia Type Iii
📧 Sign up to get email alerts when something new happens for Hyperlipoproteinemia Type Iii.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia [Phase 4]
Phase 4 clinical trial update comparing evolocumab added to standard lipid-lowering therapy versus placebo on fasting and post-fat-load lipi…
-
CLINICAL_TRIALS withdrawal · 2012-02-17Clinical Trial Update: Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder. [Phase 3]
A Phase 3 clinical trial evaluating torcetrapib and atorvastatin in subjects with Hyperlipoproteinemia Type III has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Type III Dysbetalipoproteinemia [Phase 3]
Phase 3 clinical trial update for Hyperlipoproteinemia Type III sponsored by AstraZeneca has completed.